يعرض 1 - 14 نتائج من 14 نتيجة بحث عن '"Maria Huelsebeck"', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    المصدر: Cardiovascular Therapeutics, Vol 2020 (2020)
    Cardiovascular Therapeutics

    وصف الملف: application/pdf

  12. 12

    المصدر: International Journal of Cardiology: Heart & Vasculature, Vol 23, Iss, Pp-(2019)
    International Journal of Cardiology. Heart & Vasculature

    مصطلحات موضوعية: medicine.medical_specialty, TIA, transient ischaemic attack, lcsh:Diseases of the circulatory (Cardiovascular) system, AF, atrial fibrillation, medicine.drug_class, RELOAD study, 030204 cardiovascular system & hematology, PY, patient-years, Non-valvular atrial fibrillation, Phenprocoumon, 03 medical and health sciences, 0302 clinical medicine, Rivaroxaban, Internal medicine, medicine, Clinical endpoint, ICD-10, International Classification of Diseases Tenth Revision, 030212 general & internal medicine, Renal impairment, ICH, intracranial haemorrhage, CHADS2, Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes mellitus, Stroke or transient ischaemic attack (2 points), eDDD, empirical defined daily dose, Original Paper, DOAC, direct oral anticoagulant, business.industry, Incidence (epidemiology), Hazard ratio, Atrial fibrillation, Retrospective cohort study, VKA, vitamin K antagonist, Vitamin K antagonist, medicine.disease, HR, hazard ratio, HAS-BLED, Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalised ratio, Elderly, Drugs/alcohol concomitantly, CI, confidence interval, od, once daily, lcsh:RC666-701, CHA2DS2-VASc, Congestive heart failure, Hypertension, Age ≥ 75 years (2 points), Diabetes mellitus, Stroke or transient ischaemic attack (2 points), Vascular disease, Age 65–74, Sex category (female), Cardiology and Cardiovascular Medicine, business, NVAF, non-valvular atrial fibrillation, pPDD, personalised prescribed daily dose, medicine.drug

  13. 13
  14. 14